| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/19/2006 | US20060014208 Functional assays for identifying compounds that modulate T1R2/T1R3 (sweet) taste |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060014169 Methods for obtaining directionally truncated polypeptides |
| 01/19/2006 | US20060014162 As a target for drug development against Chagas' disease |
| 01/19/2006 | US20060014153 Polypeptides as target for drugs to detect central nervous system disorders; cancer; metabolism; cardiovascular disorders |
| 01/19/2006 | US20060014143 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 01/19/2006 | US20060014136 Method of screening for protection from microbial infection |
| 01/19/2006 | US20060013829 Nucleic acid segments; coding zones; genetic engineered cells |
| 01/19/2006 | US20060013822 Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines |
| 01/19/2006 | US20060013815 Human Mob-5 (IL-24) receptors and uses thereof |
| 01/19/2006 | US20060011549 Solid compositions for selective adsorption from complex mixtures |
| 01/19/2006 | DE19930676B4 Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln A method of stabilizing insulin, insulin derivatives and / or precursors thereof in complex mixtures for storage thereof in aqueous solvents |
| 01/19/2006 | CA2569926A1 Blood pressure lowering protein hydrolysates |
| 01/19/2006 | CA2544692A1 Anti-glypican 3 antibody |
| 01/18/2006 | EP1616964A2 Process for preparative in vitro protein biosynthesis |
| 01/18/2006 | EP1616963A2 Process for producing dipeptides or dipeptide derivatives |
| 01/18/2006 | EP1616960A2 Human pancreatic cell lines: developments and uses |
| 01/18/2006 | EP1616943A1 Avian primordial germ cell (PGC) cell line and a method for long term culturing thereof |
| 01/18/2006 | EP1616942A2 Patched genes and their use |
| 01/18/2006 | EP1616885A1 Recombinant antibody recognizing dioxin and gene encoding the antibody |
| 01/18/2006 | EP1616884A2 Zcytor7 cytokine receptor and antibody thereto |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616882A2 Apo-2 receptor antibodies |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616876A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/18/2006 | EP1616578A1 Compositions and methods for delivery of genetic material |
| 01/18/2006 | EP1616020A2 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 01/18/2006 | EP1616019A2 Method for extracting collagen comprising microbial fermentation |
| 01/18/2006 | EP1615612A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 01/18/2006 | EP1373547A4 Control of glycoforms in igg |
| 01/18/2006 | EP1278851B1 Humanised antibodies to the epidermal growth factor receptor |
| 01/18/2006 | EP1127068B1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/18/2006 | EP0942917A4 Stable compositions for nucleic acid amplification and sequencing |
| 01/18/2006 | EP0882129B1 Recombinant expression of s-layer proteins |
| 01/18/2006 | EP0782630B1 Polycystic kidney disease gene |
| 01/18/2006 | CN1723282A Protein complex, process for producing the same and use thereof |
| 01/18/2006 | CN1721546A Process for preparing II-type collagen compound |
| 01/18/2006 | CN1721528A Novel human complement C1r-like serine proteinase analogue, and its encoding sequence and use |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721444A Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 01/18/2006 | CN1721443A Human receptor proteins, related reagents and methods |
| 01/18/2006 | CN1237173C Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process |
| 01/18/2006 | CN1237076C Polypeptide variants with altered effector function |
| 01/18/2006 | CN1237074C Factor VIII separation |
| 01/18/2006 | CN1237073C Gene configuration, preparing process and usage of antibacterial peptide |
| 01/18/2006 | CN1236818C Caprine arthritis-encephalitis virus provided immunoprotection against HIV-1 infection |
| 01/17/2006 | US6987211 amphibian models; for cholinergic agent screening |
| 01/17/2006 | US6987178 A recombinant expression vector; an isolated nucleic acid molecule; diagnosis of high blood pressure, obesity |
| 01/17/2006 | US6987171 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 01/17/2006 | US6987170 Cloning and expression of recombinant adhesive protein Mefp-1 of the blue mussel, Mytilus edulis |
| 01/17/2006 | US6987169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987091 Sir2 products and activities |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6987079 Prevents non- specific binding of the catalytic species to the support; high catalytic activity and permits easy separation and recovery of the catalytic species for reuse |
| 01/17/2006 | US6987016 α-galactosidases and methods for making and using them |
| 01/17/2006 | US6987007 Modified chitin-binding domain and use thereof |
| 01/17/2006 | US6987006 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987003 Modulation of RNA transport to the rough endoplasmic reticulum by staufen proteins; isolated nucleic acids encoding this protein and vectors and host cells expressing them; nucleic acid sequences and their encoded amino acid sequences; viricides |
| 01/17/2006 | US6987000 Cardiac-related Ankyrin-Repeat Protein Kinase (CARK); useful as modulating agents for regulating cardiac cellular differentiation/proliferation |
| 01/17/2006 | US6986996 Using anti-heparanase antibody to bind heparanase encoded by amino acid sequence no.1 for monitoring heparanase protein expression of heparanase gene in white blood cells in vitro; drug delivery targets; diagnosis of tumors, cancer and metastasis |
| 01/17/2006 | US6986986 subcloning nucleic acids encoding displayed polypeptides of enriched libraries from a display vector to an expression vector without the need for clonal isolation of individual members |
| 01/17/2006 | US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 01/17/2006 | US6986889 Complexing; removal from blood circulation |
| 01/17/2006 | CA2271544C Method to detect bone and other connective tissue disorders in humans and animals |
| 01/17/2006 | CA2086425C Fibroblast growth factor receptors |
| 01/12/2006 | WO2006005063A2 Methods and compositions |
| 01/12/2006 | WO2006005032A2 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 01/12/2006 | WO2006004867A2 Mammalian endonucleases and methods of use |
| 01/12/2006 | WO2006004663A2 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 01/12/2006 | WO2006004105A1 Method of producing peptide mixture, method of producing fermented milk containing antihypertensive peptide and method of producing antihypertensive peptide preparation |
| 01/12/2006 | WO2005045045A3 Recombinant microorganism |
| 01/12/2006 | WO2004101598A3 Insertion of furin protease cleavage sites in membrane proteins and uses thereof |
| 01/12/2006 | US20060009618 Expression receptors with 7 transmembrane domains in baculovirus-insect cell system |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009441 Human trace amine associated receptors |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060009378 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 01/12/2006 | US20060008918 Non-invasive diagnosis by analysis (mass spectroscopy, gas chromatography or electronic nose) of flatus or gas evolved from stool; presence or absence of a predetermined volatile compound is indicative of a disease state; diarrhea |
| 01/12/2006 | US20060008901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/12/2006 | US20060008900 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene |
| 01/12/2006 | US20060008899 Method and device for carrying out biochemical reactions with a high throughput |
| 01/12/2006 | US20060008890 food additive with a PS4 variant polypeptide derivable from a parent polypeptide having non-maltogenic exoamylase activity; baked goods; glucan 1,4-alpha-maltotetrahydrolase activity |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008888 food additive with a PS4 variant polypeptide derivable from a parent polypeptide having non-maltogenic exoamylase activity; baked goods; glucan 1,4-alpha-maltotetrahydrolase activity |
| 01/12/2006 | US20060008883 Using vector transformation to generate protein fusions with reduced immunogenicity; directed protein evolution |
| 01/12/2006 | US20060008882 Antibody or fragment that specifically binds to CK alpha -5 polypeptides; may be chimeric antibody or fragment thereof, a single chain antibody, a Fab fragment, or a F(ab')2 fragment; Western blot or an enzyme-linked immunosorbent assay; hybridoma that produces the antibody |
| 01/12/2006 | US20060008880 Mouse trace amine associated receptors and polypeptides |
| 01/12/2006 | US20060008879 Hydrolase for use in generating fermented beverage from malt; beer making |
| 01/12/2006 | US20060008878 Monomeric red fluorescent proteins |
| 01/12/2006 | US20060008877 Expression systems with sec-system secretion |
| 01/12/2006 | US20060008876 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 01/12/2006 | US20060008875 Novel TFIIH subunit |
| 01/12/2006 | US20060008874 Plant transcriptional regulators of abiotic stress |
| 01/12/2006 | US20060008873 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 01/12/2006 | US20060008872 substitutes valine for phenylalanine residue in an alpha -helix domain participating in the binding of a human cytokine protein to a corresponding receptor |
| 01/12/2006 | US20060008871 Extract of E. coli cells having mutation in ribosomal protein S12, and method for producing protein in cell-free system using the extract |
| 01/12/2006 | US20060008870 Method for universal enzymatic production of bioactive peptides |